Smooth Drug Development, e-CRO in Europe and Asia

05/28/2026

Drug development is already hard enough.
Your CRO shouldn’t make it harder.

At Smooth Drug Development, we help pharma and biotech teams move from regulatory chaos to operational clarity — faster site activation, predictable enrollment, secure data, and trials that stay on track.

✔️ Clinical trial applications approved on time
✔️ Global site activation
✔️ Faster database lock
✔️ Exceptional quality
✔️ Reliable delivery from local to global trials

Because every study deserves a smooth path forward. 💚

05/20/2026

Happy Clinical Trial Day! Thank you 🥰

05/20/2026

Happy Clinical Trials Day 2026

05/08/2026

Advancing innovation in oncology through global collaboration. 🌍🔬

Smooth Drug Development successfully supported a large multinational Phase III clinical trial in Chronic Myeloid Leukemia across 53+ sites in Russia, India, Turkey, Kazakhstan, and Pakistan.

Through strategic patient recruitment initiatives, strong regional expertise, and full-service CRO support, the study achieved enrollment targets while maintaining the highest standards of quality, compliance, and patient safety.

✔️ 180 patients enrolled
✔️ Accelerated enrollment in India
✔️ Full GCP & regulatory compliance
✔️ High-quality data delivery
✔️ Contribution to the successful launch of a novel CML therapy in Russia

At Smooth Drug Development, we combine global operational excellence with deep regional ex*****on capabilities to deliver complex late-phase oncology trials with confidence.

03/25/2026

Smooth Drug Development turned a complex oncology bioequivalence study of Olaparib into measurable success.

✔️ 28 approved sites
✔️ 90 patients enrolled
✔️ Zero delays in logistics or PK sample handling
✔️ Completed in just 9 months

As a full-service CRO, we managed everything from regulatory approvals and site activation to training, standardized meal plans, PK sample management, and multicenter coordination—delivering high-quality pharmacokinetic data on time and within budget.

With deep expertise in bioequivalence studies, multicenter activation, and end-to-end trial ex*****on, we help bring complex oncology projects to successful outcomes.

Discover how our global CRO capabilities can support your next study.

03/13/2026

Covering clinical trials in Pakistan topic at BioChina

02/13/2026

02/11/2026

Smooth Drug Development successfully conducted a Phase IIB Hepatitis D trial across 15 sites in the EAEU and Germany, enrolling 120 patients and delivering fast, high-quality ex*****on at every stage—from study planning and medical writing to regulatory support, monitoring, logistics, and a successful EMA inspection. The results supported registration in the EU and EAEU and led to acquisition by a global pharmaceutical company; FDA registration is currently in progress.

This one-minute overview showcases our full-service CRO expertise, including rescue studies, and our dedication to advancing innovative therapies for hepatitis. Ideal for hepatology KOLs and clinical leaders seeking experienced partners for clinical trials and rare-diseases.

02/04/2026

🌍 World Cancer Day is a reminder of why we do what we do — every single day.

At Smooth Drug Development, we’ve been advancing oncology clinical research for over a decade:
✔️ 74 trials across Europe, CIS, and Asia
✔️ 217 clinical sites worldwide
✔️ 2,500+ participants whose courage drives progress

As we move into 2026 with multiple new oncology programs, we continue to bridge innovation and patients — delivering end-to-end clinical development, from strategy and operations to pharmacovigilance and accelerated patient recruitment.

clinical research turns hope into life-changing treatments.

If this mission resonates, support it with a like and share 💙

01/29/2026

Learn how Smooth Drug Development performs challenging studies. A short case study on a COVID-19 project. What challenges did you face during the pandemic?